| 000 | 01868 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515175313.0 | ||
| 264 | 0 | _c20091008 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1175-5652 | ||
| 024 | 7 |
_a10.1007/BF03256139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanoui-Poitrine, Florence | |
| 245 | 0 | 0 |
_aCost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial. _h[electronic resource] |
| 260 |
_bApplied health economics and health policy _c2009 |
||
| 300 |
_a19-29 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCoronary Restenosis _xprevention & control |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetals |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMyocardial Infarction _xeconomics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 700 | 1 | _aJeanblanc, Grégoire | |
| 700 | 1 | _aAlberti, Corinne | |
| 700 | 1 | _aArmoogum, Priscilla | |
| 700 | 1 | _aCebrian, Ana | |
| 700 | 1 | _aCarrié, Didier | |
| 700 | 1 | _aHenry, Patrick | |
| 700 | 1 | _aTeiger, Emmanuel | |
| 700 | 1 | _aSlama, Michel | |
| 700 | 1 | _aSpaulding, Christian | |
| 700 | 1 | _aDurand-Zaleski, Isabelle | |
| 773 | 0 |
_tApplied health economics and health policy _gvol. 7 _gno. 1 _gp. 19-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03256139 _zAvailable from publisher's website |
| 999 |
_c18975426 _d18975426 |
||